PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2472271-12	1989	To identify the enzyme responsible for monosialylated O-glycan synthesis, we used another substrate: Gal beta 1----3GalNAc--protein obtained after galactosylation of desialylated ovine mucin by a GalNAc-R:beta 1----3 galactosyltransferase from porcine submaxillary gland.	o-glycan	54-62	solute carrier family 13 member 2	Rattus norvegicus	185-190	
2125490-0	1990	Control of mucin synthesis: the peptide portion of synthetic O-glycopeptide substrates influences the activity of O-glycan core 1 UDPgalactose:N-acetyl-alpha-galactosaminyl-R beta 3-galactosyltransferase.	o-glycan	114-122	solute carrier family 13 member 2	Rattus norvegicus	11-16	
33569470-8	2021	The target genes of the differentially expressed genes were mainly related with multicellular organism development and the mucin type O-glycan biosynthesis pathway was the most enriched KEGG pathway.	o-glycan	134-142	solute carrier family 13 member 2	Rattus norvegicus	123-128	
33644125-12	2020	Target prediction revealed an enrichment of genes related to several pathways relevant for cardiovascular disease (e.g., mucin type O-glycan biosynthesis, MAPK, Wnt, Hippo, and TGF-beta signaling).	o-glycan	132-140	solute carrier family 13 member 2	Rattus norvegicus	121-126	
28587849-12	2017	Pathway analyses using DIANA-miRPath v3.0 showed that significantly changed exosomal miRNAs were associated with extracellular matrix (ECM) receptor interaction and mucin type-O-glycan synthesis pathways, which are related with tissue fibrosis and kidney injury, respectively.	o-glycan	176-184	solute carrier family 13 member 2	Rattus norvegicus	165-170